| 1 |
Koumakis E, Cormier-Daire V, Dellal A, Debernardi M, Cortet B, Debiais F, et al. Osteogenesis imperfecta: characterization of fractures during pregnancy and post-partum. Orphanet J Rare Dis. 2022; 17(1):22.
doi: 10.1186/s13023-021-02148-x
pmid: 35090500
|
| 2 |
Botor M, Fus-Kujawa A, Uroczynska M, Stepien KL, Galicka A, Gawron K, et al. Osteogenesis imperfecta: current and prospective therapies. Biomolecules. 2021; 11(10):1493.
doi: 10.3390/biom11101493
|
| 3 |
Ruiter-Ligeti J, Czuzoj-Shulman N, Spence AR, Tulandi T, Abenhaim HA. Pregnancy outcomes in women with osteogenesis imperfecta: a retrospective cohort study. J Perinatol. 2016; 36(10):828-31.
doi: 10.1038/jp.2016.111
pmid: 27442154
|
| 4 |
Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet. 1979; 16(2):101-16.
doi: 10.1136/jmg.16.2.101
pmid: 458828
|
| 5 |
Zhytnik L, Simm K, Salumets A, Peters M, Märtson A, Maasalu K. Reproductive options for families at risk of osteogenesis imperfecta: a review. Orphanet J Rare Dis. 2020; 15(1):128.
doi: 10.1186/s13023-020-01404-w
pmid: 32460820
|
| 6 |
Keller RB, Tran TT, Pyott SM, Pepin MG, Savarirayan R, McGillivray G, et al. Monoallelic and biallelic CREB3L1 variant causes mild and severe osteogenesis imperfecta, respectively. Genet Med. 2018; 20(4):411-9.
|
| 7 |
Cozzolino M, Perelli F, Maggio L, Coccia ME, Quaranta M, Gizzo S, et al. Management of osteogenesis imperfecta type I in pregnancy: a review of literature applied to clinical practice. Arch Gynecol Obstet. 2016; 293(6):1153-9.
doi: 10.1007/s00404-016-4012-2
pmid: 26781260
|
| 8 |
Feng ZY, Chen Q, Shi CY, Wen HW, Ma K, Yang HX. A type IV osteogenesis imperfecta family and pregnancy: a case report and literature review. Chin Med J (Engl). 2012; 125(7):1358-60.
|
)
